RegentAtlantic Capital’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$347K Sell
3,846
-58
-1% -$6.37K 0.01% 535
2022
Q2
$459K Sell
3,904
-12
-0.3% -$1.72K 0.02% 455
2022
Q1
$559K Sell
3,916
-28
-0.7% -$4.28K 0.02% 435
2021
Q4
$663K Buy
3,944
+253
+7% +$41.2K 0.02% 391
2021
Q3
$556K Buy
3,691
+523
+17% +$80.6K 0.02% 412
2021
Q2
$480K Buy
3,168
+390
+14% +$61.9K 0.01% 437
2021
Q1
$416K Buy
+2,778
New +$382K 0.01% 414
2015
Q1
Sell
-830
Closed -$49.8K 446
2014
Q4
$49.8K Buy
+830
New +$48.5K ﹤0.01% 585

Other funds holding CE

RegentAtlantic Capital's CE Position: Q3 2022 in Review

RegentAtlantic Capital reduced its Celanese (CE) stake by 1.5% in Q3 2022, selling an estimated $6.37K and leaving 3,846 shares worth $347K. The position accounts for 0.01% of the portfolio, ranked #535.

RegentAtlantic Capital first reported a position in CE in Q4 2014 and has held it in 8 quarters since. The position peaked at $663K in Q4 2021. 633 funds tracked by Wall St. Rank hold CE as of Q3 2022.

  • RegentAtlantic Capital held 3,846 shares of Celanese worth $347K as of Q3 2022.
  • RegentAtlantic Capital sold 58 Celanese shares in Q3 2022, an estimated $6.37K.
  • Celanese made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #535 holding.
  • RegentAtlantic Capital first reported a position in Celanese in Q4 2014 and has held it in 8 quarters since.
  • RegentAtlantic Capital's Celanese position peaked at $663K in Q4 2021.
  • 633 funds tracked by Wall St. Rank held Celanese as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.